SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HardToFind who wrote (10856)8/15/2018 10:36:43 PM
From: Magnus1  Read Replies (1) | Respond to of 12873
 
You've ignored the point...NNVC owns the IP. To answer your redirect, yes NNVC shareholders paid for the IP., and NNVC still owns it, not Theracour.

And you only get screwed when you sell. This is the purpose of the cabal, mob, whatever one wants to call them, to chase small retail out.

The fact that the technology has not been disproven and the cabal continues to piss in the wind all over the Internet all the while unequivocally asserting imminent failure.

They are lying stock manipulators and however persistent, I will never believe their lying however sophisticated, and pervasive.



To: HardToFind who wrote (10856)8/16/2018 8:21:51 AM
From: donpat  Respond to of 12873
 
I think it was NOT NNVC shareholders.

That IP was paid for by others well before NNVC was created.

Let's get he odd thing straight around here!! ;-)

The only ones "screwed" around here are the poor saps who fall for the "crooked" POV put forward by some crooked posters who are quite wealthy screwing these poor saps I hasten to add!!

Sap #1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News